Improving Patient Compliance: Utilizing online and mobile compliance tools

Introduction

Figures outlining the losses to pharmaceutical company sales due to unfilled prescriptions range from $25bn to $30bn annually. Pharmaceutical companies planning to launch compliance campaigns must take into account patient demographics and the nature of the condition. Treatment patterns, the implications of non-compliance and the age of the patient all need to be considered. 

Report Highlights

Where appropriate, online compliance tools should be used over offline channels because they benefit from increased functionality and interactivity. 

When considering which channel to use to reach patients, providers need to consider factors such as the age of the patient and the treatment regimen. 

Pharmaceutical companies should consider investing in telemedicine and online disease management programs, both of which will improve compliance among patients. 

Reasons to Purchase

Identify the primary causes of noncompliance and relate them to specific disease areas 

Account for a number of patient variables that impact on the planning of compliance strategies 

Understand future developments in mobile and Internet technology that will drive patient compliance 

Scope

Assesses which channels are better suited to specific compliance messages 

Evaluates the patient-related variables that pharmaceutical companies need to consider when developing compliance strategies 

Publisher: Datamonitor eHealthcare Pharma Reports 

To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/Datamonitor_eHealthcare_Pharma.html#a45